DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Janssen Biotech

Janssen Biotech

  • From the Academy

    From the Academy

  • Nct02497287

    Nct02497287

  • Nct03333317

    Nct03333317

  • 2015 Annual Report

    2015 Annual Report

  • Johnson & Johnson Has Made a New Breakthrough In

    Johnson & Johnson Has Made a New Breakthrough In

  • FDA Listing of Authorized Generics As of July 1, 2021

    FDA Listing of Authorized Generics As of July 1, 2021

  • ASN Kidney Week 2020 Reimagined: Disclosures Page 1

    ASN Kidney Week 2020 Reimagined: Disclosures Page 1

  • Annual Report

    Annual Report

  • Protagonist Therapeutics Names Samuel Saks, M.D., As Chief Development Officer

    Protagonist Therapeutics Names Samuel Saks, M.D., As Chief Development Officer

  • Satu Glawe Phone: 49-172-294-6264

    Satu Glawe Phone: 49-172-294-6264

  • 2016 Annual Report

    2016 Annual Report

  • Scientific Review of Janssen Biotech Inc. COVID-19 Vaccine (Ad26.COV2.S) March 1, 2021

    Scientific Review of Janssen Biotech Inc. COVID-19 Vaccine (Ad26.COV2.S) March 1, 2021

  • 1 in the United States District Court for the Western

    1 in the United States District Court for the Western

  • Johnson & Johnson Innovation Champions Leading Edge Science with 15 New Collaborations with Potential to Impact Patients'

    Johnson & Johnson Innovation Champions Leading Edge Science with 15 New Collaborations with Potential to Impact Patients'

  • In the United States District Court for the District of Massachusetts

    In the United States District Court for the District of Massachusetts

  • Johnson & Johnson

    Johnson & Johnson

  • LSPA-2020-Annual-Report-Final.Pdf

    LSPA-2020-Annual-Report-Final.Pdf

  • Manufacturers and Wholesalers Street City ST Zip Acorda Therapeutics

    Manufacturers and Wholesalers Street City ST Zip Acorda Therapeutics

Top View
  • Johnson & Johnson Annual Report 2021
  • Johnson & Johnson 2016 Annual Report
  • Annual Report: 2017
  • Sharps Disposal Plan
  • Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)
  • 1 News Release Media Contacts
  • Older Americans, Please See Medi- See Please Ing Older Americans, Ameri- for Older Cines in Development
  • Study Protocol
  • Johnson & Johnson
  • Health Advisory Janssen (Johnson & Johnson) COVID-19 Vaccine
  • 1:20-Cv-03471 Document #: 370 Filed: 02/03/21 Page 1 of 27 Pageid #:27504
  • 20200915 MED-Project Participant List.Xlsx
  • 2020 Annual Report • • Failure to Meet Compliance Obligations in the Mcneil-PPC, Inc
  • Contract Drugs List Part 1 – Prescription Drugs (A Through D) Page Updated: November 2020
  • Johnson & Johnson
  • 2019 Janssen U.S. Transparency Report Notes on This Report
  • EXHIBIT 21 SUBSIDIARIES Johnson & Johnson, a New Jersey
  • Faculty Disclosure Index DDW Sponsoring Society CME Statements


© 2024 Docslib.org    Feedback